Patient-derived organoids reveal strain-specific efficacy of engineered bacteria in colorectal cancer

Katherine O’Connor; Deniz Erkok; Josephine A. Wright; Paige Steppe; Kate R. Barratt; Laura Vrbanac; Dan L. Worthley; Susan L. Woods; Jeff Hasty
Current Treatment Options in Rheumatology · Springer Nature · 2026-11-18

Аннотация

Communications Medicine, Published online: 18 November 2026; doi:10.1038/s43856-026-01992-x ED Summary: O’Connor et al. use a patient-derived organoid co-culture platform to evaluate engineered bacterial therapies for colorectal cancer and capture strain- and patient-specific responses. Both bacteria preferentially colonise tumours, but attenuated Salmonella shows stronger colonisation and biological effects than E. coli Nissle.

Читать у издателя →

Похожие статьи